Abstract
Snakebite envenoming represents a major health threat intropical parts of the developing world1. Animal-derivedantisera currently constitute the only effective treatment option,but are associated with severe side effects due toincompatibility with the human immune system. We aim atdiscovering human antibodies that target the medically mostimportant toxins from N. melanoleuca venom using phagedisplay technology.
Info
Conference Poster, 2016
UN SDG Classification
DK Main Research Area
Science/Technology
